Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation
Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
There are no standardized plasma volume replacement protocols during liver transplantation
surgery. The current study is designed to compare efficacy, safety, and costs of
perioperative volume replacement with Voluven (Hydroxyethyl starch 130/0.4) and albumin in
patients undergoing liver transplantation.